Related Content
DAIC Editor, Dave Fornell, interviews Jim Hermiller, M.D., FACC, director of interventional cardiology, St. Vincent ...
September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective ...
(UPDATE: read the Sept. 8, 2017 article "Abbott Will End Sales of Absorb Bioresorbable Stent") A key prediction for ...
August 12, 2014 — The Centers for Medicare and Medicaid (CMS) took action to improve access to Abbott’s MitraClip system ...
July 29, 2014 — Mary York knew the walk from the living room to the bedroom should not have been difficult for her ...
As a cardiovascular technology magazine editor, I keep tabs on what technology is in development and often have the ...
May 8, 2014 — Abbott announced its catheter-based MitraClip therapy has received Health Canada approval, providing ...
April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the ...
April 1, 2014 — The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat ...
The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights ...